Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
4.480
-0.120 (-2.61%)
At close: Apr 9, 2026, 4:00 PM EDT
4.453
-0.028 (-0.61%)
After-hours: Apr 9, 2026, 5:52 PM EDT
Niagen Bioscience Stock Forecast
Stock Price Forecast
The 3 analysts that cover Niagen Bioscience stock have a consensus rating of "Strong Buy" and an average price target of $16, which forecasts a 257.14% increase in the stock price over the next year. The lowest target is $12 and the highest is $23.
Price Target: $16 (+257.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +190.18% | Mar 31, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +190.18% | Mar 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +212.50% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +167.86% | Aug 11, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $16 | Strong Buy | Maintains | $13 → $16 | +257.14% | Jun 10, 2025 |
Financial Forecast
Revenue This Year
150.79M
from 129.42M
Increased by 16.51%
Revenue Next Year
172.77M
from 150.79M
Increased by 14.58%
EPS This Year
0.28
from 0.20
Increased by 38.98%
EPS Next Year
0.35
from 0.28
Increased by 26.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 163.1M | 183.0M | |
| Avg | 150.8M | 172.8M | |
| Low | 141.1M | 159.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.0% | 21.3% | |
| Avg | 16.5% | 14.6% | |
| Low | 9.0% | 5.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.35 | 0.39 | |
| Avg | 0.28 | 0.35 | |
| Low | 0.23 | 0.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 73.3% | 39.8% | |
| Avg | 39.0% | 26.6% | |
| Low | 12.7% | 12.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.